# Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.

> **NCT06346925** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Adult Patients With Chronic Primary ITP
- Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy

## Interventions

- **DRUG:** Herombopag Olamine Tablets

## Key facts

- **NCT ID:** NCT06346925
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04
- **Primary completion:** 2024-07
- **Final completion:** 2024-07
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06346925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06346925, "Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT06346925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*